. MA plot showing the average expression level and fold-change of each gene in CAST/EiJ control relative to CAST/EiJ exposed to 1,3-butadiene (BD). Genes with significantly higher expression in CAST/EiJ control relative to CAST/EiJ exposed at an FDR of 10% are green, whereas genes with significantly higher expression in CAST/EiJ exposed relative to CAST/EiJ control at an FDR of 10% are orange. Nonsignificant genes are in gray. Figure S5 . MA plot showing the average expression level and fold-change of each gene in C57BL/6J control relative to C57BL/6J exposed to 1,3-butadiene (BD). Genes with significantly higher expression in C57BL/6J control relative to C57BL/6J exposed at an FDR of 10% are blue, whereas genes with significantly higher expression in C57BL/6J exposed relative to C57BL/6J control at an FDR of 10% are red. Nonsignificant genes are in gray. Figure S6 . Motif enrichments in differentially accessible regions (DARs) in 1,3-butadieneexposed mice C57BL/6J relative to clean air-exposed control mice. Figure S7 . Chromatin accessibility and target gene expression at distal regions containing the Sp1 motif (A) On average, distal regions containing the Sp1 motif decrease in chromatin accessibility following 1,3-butadiene (BD) exposure in C57BL/6J to more closely resemble those regions in CAST/EiJ. (B) Similarly, genes associated with these regions also decrease in expression following BD exposure in C57BL/6J. Table S1 . Sequencing statistics. Table S2 . Differential mRNA expression analysis results, as determined by DESeq2. Table S3 . Pathway enrichment based on gene expression profiles in the lung of CAST/EiJ mice exposed to clean air compared to that of C57BL/6J mice, using GSAA and the REACTOME database. Table S4 . Differential miRNA expression analysis results, as determined by DESeq2, and denotation of master regulators of mRNA expression as determined by miRhub analysis. Table S5 . Differential ATAC-seq chromatin accessibility analysis results, as determined by DESeq2. Table S6 . Pathway enrichment based on chromatin accessibility profiles in the lung of CAST/EiJ mice exposed to clean air compared to that of C57BL/6J mice exposed to clean air, using GSAA and the REACTOME database. Table S7 . Pathway enrichment based on gene expression profiles in the lung of CAST/EiJ mice exposed to 1,3-butadiene compared to that of CAST/EiJ mice exposed to clean air, using GSAA and the REACTOME database. Table S8 . Pathway enrichment based on gene expression profiles in the lung of C57BL/6J mice exposed to 1,3-butadiene compared to that of C57BL/6J mice exposed to clean air, using GSAA and the REACTOME database. Table S9 . Geneset enrichment based on 719 genes linked to one of the 2,188 proximal SP1-containing DARs between C57BL/6J and CAST/EiJ at baseline, using GSAA and the REACTOME database. Table S10 . Pathway enrichment based on differentially expressed genes and/or differentially accessible regions (DARs) in the lung of C57BL/6J mice exposed to 1,3 butadiene compared to C57BL/6J mice exposed to clean air, grouped by their patterns of expression/accessibility across both strains and conditions (Figure 5 ). Figure S1 . Air concentration of 1,3-butadiene inside the inhalation chamber. Data are presented as mean±SD. . Genes with significantly higher expression in CAST/EiJ control relative to CAST/EiJ exposed at an FDR of 10% are green, whereas genes with significantly higher expression in CAST/EiJ exposed relative to CAST/EiJ control at an FDR of 10% are orange. Nonsignificant genes are in gray. Figure S5 . MA plot showing the average expression level and fold-change of each gene in C57BL/6J control relative to C57BL/6J exposed to 1,3-butadiene (BD). Genes with significantly higher expression in C57BL/6J control relative to C57BL/6J exposed at an FDR of 10% are blue, whereas genes with significantly higher expression in C57BL/6J exposed relative to C57BL/6J control at an FDR of 10% are red. Nonsignificant genes are in gray. Figure S6 . Motif enrichments in differentially accessible regions (DARs) in 1,3-butadiene-exposed mice C57BL/6J relative to clean air-exposed control mice. Excel Table S1 . Sequencing statistics.
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